[go: up one dir, main page]

FR2746412B1 - Purification d'adn plasmidique de qualite pharmaceutique - Google Patents

Purification d'adn plasmidique de qualite pharmaceutique

Info

Publication number
FR2746412B1
FR2746412B1 FR9603519A FR9603519A FR2746412B1 FR 2746412 B1 FR2746412 B1 FR 2746412B1 FR 9603519 A FR9603519 A FR 9603519A FR 9603519 A FR9603519 A FR 9603519A FR 2746412 B1 FR2746412 B1 FR 2746412B1
Authority
FR
France
Prior art keywords
purification
plasmid dna
pharmaceutical quality
pharmaceutical
quality
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR9603519A
Other languages
English (en)
Other versions
FR2746412A1 (fr
Inventor
Monique Ollivier
Pierre Wils
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharma SA
Original Assignee
Rhone Poulenc Rorer SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to FR9603519A priority Critical patent/FR2746412B1/fr
Application filed by Rhone Poulenc Rorer SA filed Critical Rhone Poulenc Rorer SA
Priority to BR9708227A priority patent/BR9708227A/pt
Priority to CZ19982984A priority patent/CZ295587B6/cs
Priority to PCT/FR1997/000472 priority patent/WO1997035002A1/fr
Priority to AU21661/97A priority patent/AU730755B2/en
Priority to SK1291-98A priority patent/SK129198A3/sk
Priority to JP9533199A priority patent/JP2000506736A/ja
Priority to CA002249465A priority patent/CA2249465A1/fr
Priority to HU9902152A priority patent/HU225426B1/hu
Priority to EP97914411A priority patent/EP0902835A1/fr
Priority to KR10-1998-0707410A priority patent/KR100502116B1/ko
Priority to IL12626897A priority patent/IL126268A0/xx
Priority to ZA9702462A priority patent/ZA972462B/xx
Publication of FR2746412A1 publication Critical patent/FR2746412A1/fr
Application granted granted Critical
Publication of FR2746412B1 publication Critical patent/FR2746412B1/fr
Priority to US09/153,838 priority patent/US6730781B1/en
Priority to NO984342A priority patent/NO984342D0/no
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1003—Extracting or separating nucleic acids from biological samples, e.g. pure separation or isolation methods; Conditions, buffers or apparatuses therefor
    • C12N15/1006—Extracting or separating nucleic acids from biological samples, e.g. pure separation or isolation methods; Conditions, buffers or apparatuses therefor by means of a solid support carrier, e.g. particles, polymers
    • C12N15/101—Extracting or separating nucleic acids from biological samples, e.g. pure separation or isolation methods; Conditions, buffers or apparatuses therefor by means of a solid support carrier, e.g. particles, polymers by chromatography, e.g. electrophoresis, ion-exchange, reverse phase
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6806—Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Analytical Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Immunology (AREA)
  • Plant Pathology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Saccharide Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
FR9603519A 1996-03-21 1996-03-21 Purification d'adn plasmidique de qualite pharmaceutique Expired - Fee Related FR2746412B1 (fr)

Priority Applications (15)

Application Number Priority Date Filing Date Title
FR9603519A FR2746412B1 (fr) 1996-03-21 1996-03-21 Purification d'adn plasmidique de qualite pharmaceutique
KR10-1998-0707410A KR100502116B1 (ko) 1996-03-21 1997-03-17 약제성 플라스미드 디엔에이의 정제
PCT/FR1997/000472 WO1997035002A1 (fr) 1996-03-21 1997-03-17 Purification d'adn plasmidique de qualite pharmaceutique
AU21661/97A AU730755B2 (en) 1996-03-21 1997-03-17 Purification of plasmid DNA of pharmaceutical quality
SK1291-98A SK129198A3 (en) 1996-03-21 1997-03-17 Purification of pharmaceutical-grade plasmid dna
JP9533199A JP2000506736A (ja) 1996-03-21 1997-03-17 医薬品質のプラスミドｄｎａの精製
CA002249465A CA2249465A1 (fr) 1996-03-21 1997-03-17 Purification d'adn plasmidique de qualite pharmaceutique
HU9902152A HU225426B1 (en) 1996-03-21 1997-03-17 Method for purification of double stranded plasmid dna
BR9708227A BR9708227A (pt) 1996-03-21 1997-03-17 Processo de purificação de dna duplo filamento de pureza farmacêutica preparação de dna plasmídico recombinante e composição farmacêutica
CZ19982984A CZ295587B6 (cs) 1996-03-21 1997-03-17 Purifikace plazmidové DNA farmaceutické kvality
IL12626897A IL126268A0 (en) 1996-03-21 1997-03-17 Purification of plasmid dna of pharmaceutical quality
EP97914411A EP0902835A1 (fr) 1996-03-21 1997-03-17 Purification d'adn plasmidique de qualite pharmaceutique
ZA9702462A ZA972462B (en) 1996-03-21 1997-03-20 Purification of plasmid DNA of pharmaceutical quality.
US09/153,838 US6730781B1 (en) 1996-03-21 1998-09-15 Purification of plasmid DNA of pharmaceutical quality
NO984342A NO984342D0 (no) 1996-03-21 1998-09-18 Rensing av plasmid-DNA av farmas°ytisk kvalitet

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9603519A FR2746412B1 (fr) 1996-03-21 1996-03-21 Purification d'adn plasmidique de qualite pharmaceutique

Publications (2)

Publication Number Publication Date
FR2746412A1 FR2746412A1 (fr) 1997-09-26
FR2746412B1 true FR2746412B1 (fr) 1998-06-12

Family

ID=9490391

Family Applications (1)

Application Number Title Priority Date Filing Date
FR9603519A Expired - Fee Related FR2746412B1 (fr) 1996-03-21 1996-03-21 Purification d'adn plasmidique de qualite pharmaceutique

Country Status (15)

Country Link
US (1) US6730781B1 (fr)
EP (1) EP0902835A1 (fr)
JP (1) JP2000506736A (fr)
KR (1) KR100502116B1 (fr)
AU (1) AU730755B2 (fr)
BR (1) BR9708227A (fr)
CA (1) CA2249465A1 (fr)
CZ (1) CZ295587B6 (fr)
FR (1) FR2746412B1 (fr)
HU (1) HU225426B1 (fr)
IL (1) IL126268A0 (fr)
NO (1) NO984342D0 (fr)
SK (1) SK129198A3 (fr)
WO (1) WO1997035002A1 (fr)
ZA (1) ZA972462B (fr)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7026468B2 (en) 1996-07-19 2006-04-11 Valentis, Inc. Process and equipment for plasmid purification
US7807822B2 (en) 1996-08-01 2010-10-05 Robert Bridenbaugh Methods for purifying nucleic acids
US6214586B1 (en) * 1997-12-08 2001-04-10 Genzyme Corporation Method for purifying plasmid DNA and plasmid DNA substantially free of genomic DNA
PT1290156E (pt) * 2000-05-26 2008-02-21 Centelion Purificação de uma formação de hélice tripla com um oligonucleótido imobilizado
FR2822476B1 (fr) * 2001-03-23 2004-04-02 Aventis Pharma Sa Procedes de purification et de detection de sequences cibles d'adn double brin par interaction triple helice
WO2002077274A2 (fr) * 2001-03-23 2002-10-03 Gencell S.A. Procedes de purification et de detection de sequences cibles d'adn double brin par interaction triple helice.
WO2004024283A2 (fr) 2002-09-13 2004-03-25 Valentis, Inc. Appareil et procede de purification a l'echelle de la chimie preparatoire d'acides nucleiques
ES2748130T3 (es) 2003-05-30 2020-03-13 Vgxi Inc Dispositivos y métodos para la producción de un biomaterial
ATE532853T1 (de) * 2003-09-17 2011-11-15 Aventis Pharma Sa Verfahren zur herstellung einer plasmid-dna in pharmazeutischer qualität
CN101006170A (zh) * 2004-04-19 2007-07-25 森特利昂公司 纯化质粒dna的方法
EP2246413A3 (fr) * 2004-04-19 2011-10-26 Centelion Procédé de préparation d'ADN plasmide de qualité pharmaceutique
MX2007001847A (es) 2004-08-16 2007-04-13 Nature Technology Corp Cepas mejoradas de e.coli para la produccion de adn de plasmido.
EP1817423B1 (fr) 2004-11-30 2015-01-07 Merial Ltd. Melangeurs pour chimiolyse de cellules
US20120258502A1 (en) * 2011-04-08 2012-10-11 Vinod Pandiripally Method of producing recombinant plasmid dna using substantially solid growth medium
US20120283503A1 (en) * 2011-04-29 2012-11-08 The Johns Hopkins University Nanoparticle loaded stem cells and their use in mri guided hyperthermia
CN116790578B (zh) * 2023-08-22 2023-12-12 赛奥斯博生物科技(北京)有限公司 一种基于碱裂解法快速纯化质粒的生产工艺

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3888079T2 (de) * 1987-10-22 1994-07-14 Asahi Optical Co Ltd Poröses keramisches Material.
JPH01135792A (ja) * 1987-11-20 1989-05-29 Mitsui Toatsu Chem Inc 核酸の分離・精製方法
CA2006008C (fr) * 1988-12-20 2000-02-15 Donald J. Kessler Methode pour obtenir des oligonucleotides synthetiques qui se lient specifiquement a des sites cibles sur des molecules d'adn double brin, en formant un triplex colineaire; methode d'utilisation de ces oligonucleotides synthetiques
AU6125294A (en) * 1993-01-13 1994-08-15 Genetics Institute Inc. Process for producing m-csf 223
US5503816A (en) * 1993-09-27 1996-04-02 Becton Dickinson And Company Silicate compounds for DNA purification
EP0775150B1 (fr) * 1994-02-07 1999-04-28 QIAGEN GmbH Procede de reduction ou d'elimination d'endotoxines
US5576196A (en) * 1995-01-13 1996-11-19 Vical Incorporated Process for reducing RNA concentration in a mixture of biological material using diatomaceous earth
EP0880536B2 (fr) 1996-02-06 2015-08-05 Roche Diagnostics GmbH Procede pour la preparation d'acide nucleique purifie et utilisation de ce dernier

Also Published As

Publication number Publication date
KR20000064693A (ko) 2000-11-06
CA2249465A1 (fr) 1997-09-25
SK129198A3 (en) 1999-03-12
BR9708227A (pt) 1999-07-27
AU730755B2 (en) 2001-03-15
US6730781B1 (en) 2004-05-04
EP0902835A1 (fr) 1999-03-24
HUP9902152A2 (hu) 1999-11-29
NO984342L (no) 1998-09-18
HU225426B1 (en) 2006-11-28
CZ298498A3 (cs) 1999-01-13
JP2000506736A (ja) 2000-06-06
KR100502116B1 (ko) 2005-12-20
NO984342D0 (no) 1998-09-18
CZ295587B6 (cs) 2005-08-17
AU2166197A (en) 1997-10-10
IL126268A0 (en) 1999-05-09
WO1997035002A1 (fr) 1997-09-25
ZA972462B (en) 1997-09-29
FR2746412A1 (fr) 1997-09-26
HUP9902152A3 (en) 2001-04-28

Similar Documents

Publication Publication Date Title
FR2746412B1 (fr) Purification d'adn plasmidique de qualite pharmaceutique
DE69530183D1 (de) Herstellung von plasmid dns von pharmazeutischer güte
EP1000174A4 (fr) Technique de purification d'acides nucleiques viraux
EP1018549A4 (fr) Technique d'isolation d'adn
EP0521108A4 (en) Site specific cleavage of single-stranded dna
HUP9801207A3 (en) Therapeutic compositions for transfecting nucleic acids and use thereof
DZ2494A1 (fr) Composition pharmaceutique d'oméprazole.
EP1005562A4 (fr) Production et purification d'acide succinique
EP0959877A4 (fr) Correction des defaillances genetiques a l'aide de chaperons chimiques
FR2734568B1 (fr) Nouveaux variants de l'apolipoproteine
DE69507215D1 (de) Reinigung von Bisphenol-A
FR2753204B1 (fr) Procede de preparation d'adn plasmidique
NO986177L (no) FremgangsmÕte for fremstilling av terapeutisk DNA
EP1003519A4 (fr) Suppression de l'activite de la cycline kinase 2 pour prevenir et traiter des infections virales a adn
EP0826033A4 (fr) Gene de l'ataxie-telangiectasie
FR2687687B1 (fr) Procede pour mesurer la taille de fragments d'adn.
TR199701051A3 (tr) 2' -Fluoro-5-metil- -l-arabino-furanosilüridin hazirlanma prosesi
FI950977A (fi) Menetelmä jodattujen varjoaineiden valmistamiseksi ja puhdistamiseksi
FR2636738B1 (fr) Procede et installation de sequencage de l'adn
IL123849A0 (en) Pharmaceutical composition useful for nucleic acid transfection and use thereof
FR2754816B1 (fr) Procede de purification d'hydrogenochlorofluoroethanes
HUP0004577A3 (en) Novel class of nucleic acid cationic transfecting agents
FI970765A (fi) Dinukleotidi- ja oligonukleotidianalogien välituotteet
FR2771091B1 (fr) Procede d'hydrogenation de dinitriles
FR2760024B1 (fr) Procede de caracterisation de duplex d'acide nucleique

Legal Events

Date Code Title Description
CD Change of name or company name
ST Notification of lapse

Effective date: 20091130